Trial Outcomes & Findings for Prevention of Seroma Formation and Wound Complications Using NPWT Devices (NCT NCT02147288)
NCT ID: NCT02147288
Last Updated: 2017-01-30
Results Overview
Quantitative assessment of fluid collection in pre-defined anatomic regions will be performed via ultrasound examination approximately two weeks following removal of drains (either JP or NPWT-associated)
COMPLETED
NA
46 participants
Two weeks following drain removal
2017-01-30
Participant Flow
Patients were recruited for the "panniculectomy on negative pressure wound therapy (NPWT)" and "panniculectomy on Jackson-Pratt (JP) drains" groups. Patients were not recruited for the remaining arm;s the manufacturer, Smith \& Nephew, temporarily halted on the distribution of the device (Renasys\*GO negative pressure wound management system).
Participant milestones
| Measure |
Panniculectomy on Jackson Pratt (JP) Drains
Standard of Care
|
Panniculectomy on Negative Pressure Wound Therapy (NPWT)
The Smith\&Nephew Renasys\*GO device connected to non-compressible drains will be applied to the panniculectomy patients enrolled in this arm.
Renasys\*GO Negative Pressure Wound Therapy System: Continuous, mechanical negative pressure wound therapy applied to drain in the immediate post-operative period (vs standard, closed-suction JP drains).
|
Breast Recon With Acellular Dermal Matrix (ADM) on NPWT
|
Breast Recon With ADM on Jackson-Pratt (JP) Drains
|
Lipoabdominoplasty on NPWT
|
Lipoabdominoplasty on JP Drains
|
Abdominoplasty on NPWT
|
Abdominoplasty on JP Drains
|
Ventral Hernia Repair (VHR) on NPWT
|
Ventral Hernia Repair (VHR) on JP Drains
|
|---|---|---|---|---|---|---|---|---|---|---|
|
Overall Study
STARTED
|
22
|
24
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Overall Study
COMPLETED
|
21
|
22
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Overall Study
NOT COMPLETED
|
1
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
Reasons for withdrawal
| Measure |
Panniculectomy on Jackson Pratt (JP) Drains
Standard of Care
|
Panniculectomy on Negative Pressure Wound Therapy (NPWT)
The Smith\&Nephew Renasys\*GO device connected to non-compressible drains will be applied to the panniculectomy patients enrolled in this arm.
Renasys\*GO Negative Pressure Wound Therapy System: Continuous, mechanical negative pressure wound therapy applied to drain in the immediate post-operative period (vs standard, closed-suction JP drains).
|
Breast Recon With Acellular Dermal Matrix (ADM) on NPWT
|
Breast Recon With ADM on Jackson-Pratt (JP) Drains
|
Lipoabdominoplasty on NPWT
|
Lipoabdominoplasty on JP Drains
|
Abdominoplasty on NPWT
|
Abdominoplasty on JP Drains
|
Ventral Hernia Repair (VHR) on NPWT
|
Ventral Hernia Repair (VHR) on JP Drains
|
|---|---|---|---|---|---|---|---|---|---|---|
|
Overall Study
post-operative hematoma
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Overall Study
complications from concurrent hernia rep
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
Baseline Characteristics
Prevention of Seroma Formation and Wound Complications Using NPWT Devices
Baseline characteristics by cohort
| Measure |
Panniculectomy on JP Drains
n=21 Participants
Standard of Care
|
Panniculectomy on NPWT
n=22 Participants
The Smith\&Nephew Renasys\*GO device connected to non-compressible drains will be applied to the panniculectomy patients enrolled in this arm.
Renasys\*GO Negative Pressure Wound Therapy System: Continuous, mechanical negative pressure wound therapy applied to drain in the immediate post-operative period (vs standard, closed-suction JP drains).
|
Total
n=43 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
41 years
n=5 Participants
|
46 years
n=7 Participants
|
43.6 years
n=5 Participants
|
|
Gender
Female
|
18 Participants
n=5 Participants
|
21 Participants
n=7 Participants
|
39 Participants
n=5 Participants
|
|
Gender
Male
|
3 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
4 Participants
n=5 Participants
|
|
Diabetes history
diabetic
|
6 participants
n=5 Participants
|
3 participants
n=7 Participants
|
9 participants
n=5 Participants
|
|
Diabetes history
non-diabetic
|
15 participants
n=5 Participants
|
19 participants
n=7 Participants
|
34 participants
n=5 Participants
|
|
Smoking status
smokers
|
3 participants
n=5 Participants
|
4 participants
n=7 Participants
|
7 participants
n=5 Participants
|
|
Smoking status
non-smokers
|
18 participants
n=5 Participants
|
18 participants
n=7 Participants
|
36 participants
n=5 Participants
|
|
Prior abdominal surgery
yes
|
15 participants
n=5 Participants
|
19 participants
n=7 Participants
|
34 participants
n=5 Participants
|
|
Prior abdominal surgery
no
|
6 participants
n=5 Participants
|
3 participants
n=7 Participants
|
9 participants
n=5 Participants
|
|
Body mass Index
|
32.3 kg/m^2
n=5 Participants
|
30.4 kg/m^2
n=7 Participants
|
31.32 kg/m^2
n=5 Participants
|
|
Pre-operative prealbumin
|
20.3 milligrams per deciliter
n=5 Participants
|
21.4 milligrams per deciliter
n=7 Participants
|
20.9 milligrams per deciliter
n=5 Participants
|
|
Incision length
|
52.3 centimeters
n=5 Participants
|
56.6 centimeters
n=7 Participants
|
54.5 centimeters
n=5 Participants
|
|
Specimen weight
|
3.07 kilograms
n=5 Participants
|
2.61 kilograms
n=7 Participants
|
2.83 kilograms
n=5 Participants
|
|
Drain duration
|
16 days
n=5 Participants
|
14 days
n=7 Participants
|
15 days
n=5 Participants
|
PRIMARY outcome
Timeframe: Two weeks following drain removalPopulation: Among 21 completers (standard of care group); one outlier was excluded from the analysis; 20 subjects were analyzed. Among 22 completers (experimental group), one outlier and 1 who did not have an ultrasound (i.e., fluid was not measured) were excluded, leaving 20 subjects for analysis.
Quantitative assessment of fluid collection in pre-defined anatomic regions will be performed via ultrasound examination approximately two weeks following removal of drains (either JP or NPWT-associated)
Outcome measures
| Measure |
Panniculectomy on JP Drains
n=20 Participants
Standard of Care
|
Panniculectomy on NPWT
n=20 Participants
The Smith\&Nephew Renasys\*GO device connected to non-compressible drains will be applied to the panniculectomy patients enrolled in this arm.
Renasys\*GO Negative Pressure Wound Therapy System: Continuous, mechanical negative pressure wound therapy applied to drain in the immediate post-operative period (vs standard, closed-suction JP drains).
|
|---|---|---|
|
Post-operative Seroma Formation
|
16.9 cm^3
Interval 0.0 to 132.0
|
10.1 cm^3
Interval 0.0 to 45.9
|
Adverse Events
Panniculectomy on JP Drains
Panniculectomy on NPWT
Serious adverse events
| Measure |
Panniculectomy on JP Drains
n=22 participants at risk
Standard of Care
|
Panniculectomy on NPWT
n=24 participants at risk
The Smith\&Nephew Renasys\*GO device connected to non-compressible drains will be applied to the panniculectomy patients enrolled in this arm.
Renasys\*GO Negative Pressure Wound Therapy System: Continuous, mechanical negative pressure wound therapy applied to drain in the immediate post-operative period (vs standard, closed-suction JP drains).
|
|---|---|---|
|
Skin and subcutaneous tissue disorders
post-operative hematoma
|
4.5%
1/22 • Number of events 1
|
4.2%
1/24 • Number of events 1
|
|
Skin and subcutaneous tissue disorders
abcess with infected mesh
|
0.00%
0/22
|
4.2%
1/24 • Number of events 1
|
Other adverse events
| Measure |
Panniculectomy on JP Drains
n=22 participants at risk
Standard of Care
|
Panniculectomy on NPWT
n=24 participants at risk
The Smith\&Nephew Renasys\*GO device connected to non-compressible drains will be applied to the panniculectomy patients enrolled in this arm.
Renasys\*GO Negative Pressure Wound Therapy System: Continuous, mechanical negative pressure wound therapy applied to drain in the immediate post-operative period (vs standard, closed-suction JP drains).
|
|---|---|---|
|
Skin and subcutaneous tissue disorders
seroma
|
18.2%
4/22 • Number of events 4
|
4.2%
1/24 • Number of events 1
|
|
Skin and subcutaneous tissue disorders
wound dehiscence
|
18.2%
4/22 • Number of events 4
|
8.3%
2/24 • Number of events 2
|
|
Skin and subcutaneous tissue disorders
cellulitis
|
9.1%
2/22 • Number of events 2
|
8.3%
2/24 • Number of events 2
|
|
Skin and subcutaneous tissue disorders
stitch absess
|
0.00%
0/22
|
4.2%
1/24 • Number of events 1
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place